These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 36012615)
1. Combined Treatment of Bronchial Epithelial Calu-3 Cells with Peptide Nucleic Acids Targeting miR-145-5p and miR-101-3p: Synergistic Enhancement of the Expression of the Cystic Fibrosis Transmembrane Conductance Regulator ( Papi C; Gasparello J; Zurlo M; Manicardi A; Corradini R; Cabrini G; Gambari R; Finotti A Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012615 [TBL] [Abstract][Full Text] [Related]
2. A Peptide Nucleic Acid (PNA) Masking the miR-145-5p Binding Site of the 3'UTR of the Cystic Fibrosis Transmembrane Conductance Regulator ( Sultan S; Rozzi A; Gasparello J; Manicardi A; Corradini R; Papi C; Finotti A; Lampronti I; Reali E; Cabrini G; Gambari R; Borgatti M Molecules; 2020 Apr; 25(7):. PubMed ID: 32260566 [TBL] [Abstract][Full Text] [Related]
3. Treatment of human airway epithelial Calu-3 cells with a peptide-nucleic acid (PNA) targeting the microRNA miR-101-3p is associated with increased expression of the cystic fibrosis Transmembrane Conductance Regulator () gene. Fabbri E; Tamanini A; Jakova T; Gasparello J; Manicardi A; Corradini R; Finotti A; Borgatti M; Lampronti I; Munari S; Dechecchi MC; Cabrini G; Gambari R Eur J Med Chem; 2021 Jan; 209():112876. PubMed ID: 33127171 [TBL] [Abstract][Full Text] [Related]
4. A Peptide Nucleic Acid against MicroRNA miR-145-5p Enhances the Expression of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in Calu-3 Cells. Fabbri E; Tamanini A; Jakova T; Gasparello J; Manicardi A; Corradini R; Sabbioni G; Finotti A; Borgatti M; Lampronti I; Munari S; Dechecchi MC; Cabrini G; Gambari R Molecules; 2017 Dec; 23(1):. PubMed ID: 29286300 [TBL] [Abstract][Full Text] [Related]
5. Differential effects on the miRNome of the treatment of human airway epithelial Calu-3 cells with peptide-nucleic acids (PNAs) targeting microRNAs miR-101-3p and miR-145-5p: Next generation sequencing datasets. Gasparello J; Fabbri E; Gambari R; Finotti A Data Brief; 2021 Apr; 35():106718. PubMed ID: 33553515 [TBL] [Abstract][Full Text] [Related]
6. Peptide Nucleic Acids as miRNA Target Protectors for the Treatment of Cystic Fibrosis. Zarrilli F; Amato F; Morgillo CM; Pinto B; Santarpia G; Borbone N; D'Errico S; Catalanotti B; Piccialli G; Castaldo G; Oliviero G Molecules; 2017 Jul; 22(7):. PubMed ID: 28698463 [TBL] [Abstract][Full Text] [Related]
10. The Cystic Fibrosis Transmembrane Conductance Regulator Gene (CFTR) Is under Post-Transcriptional Control of microRNAs: Analysis of the Effects of agomiRNAs Mimicking miR-145-5p, miR-101-3p, and miR-335-5p. Papi C; Gasparello J; Zurlo M; Cosenza LC; Gambari R; Finotti A Noncoding RNA; 2023 Apr; 9(2):. PubMed ID: 37104011 [TBL] [Abstract][Full Text] [Related]
11. Post-transcriptional regulation of cystic fibrosis transmembrane conductance regulator expression and function by microRNAs. Ramachandran S; Karp PH; Osterhaus SR; Jiang P; Wohlford-Lenane C; Lennox KA; Jacobi AM; Praekh K; Rose SD; Behlke MA; Xing Y; Welsh MJ; McCray PB Am J Respir Cell Mol Biol; 2013 Oct; 49(4):544-51. PubMed ID: 23646886 [TBL] [Abstract][Full Text] [Related]